Complex, costly conditions: A strategic imperative for payers and employers
The human toll of cancer, heart disease, kidney disease and musculoskeletal conditions is substantial. Current spending on these condition categories will continue to rise dramatically, significantly driven by patient complexity, hospitalizations, surgery and pharmaceutical costs. Addressing these conditions requires a comprehensive benefit management plan designed to improve clinical outcomes and the care experience for consumers while reducing the total cost of care.
Read more...